Live Report – 2018 BioJapan: Witness Japan’s biotechnology industry development policy and the innovation of pharmaceutical industry

2018 BioJapan was launched on October 10th at Pacifico Yokohama National Convention Hall. GeneOnline listed some of the highlights shared by two key opinion leaders in medicine.

Concentrate on the development of biotechnology in order to solve the issues on society.

Mazakazu Tokura, the president of SUMITOMO CHEMICAL , also a member of Council for Science, Technology and Innovation (CSTI), mentioned that Japanese government has outlined “Society 5.0” project in “Japan Revitalization Strategy”, in order to integrate the relevant units and implement the effective resource allocation and structural reform.

Regarding to this, Japanese government’s appeal is to let the policy and technology development become closer, more organized and flexible, and commit to expanding the market and accelerating the development of computer science and biotechnology.

The technology integration is real data and domain technology for biotechnology, which combines big data in various fields with cutting edge technologies such as genetic technology, AIoT, bioinformatics, etc. As well as connects to the country that has sound system on biomedical, such as the United States, United Kingdom, Germany, etc., in order to become the well-known country in global biotechnology industry.

The future of drug development and innovation

George Nakayama, president of Japan Pharmaceutical Manufacturers Association (JPMA), introduced that JPMA consists of 71 research-based pharmaceuticals in Japan and is a research-oriented voluntary organization.

He mentioned that Japan should work hard in three directions to catch up with the United States. To begin with, the establishment of the infrastructure, including the establishment of a health care database, such as genome and clinical diagnostic information, and the construction of ID facilities. Then, in order to provide sufficient funds for basic scientific research, the government and industry should cooperate to create profits. Finally, the government should establish an ecosystem without borders, especially establish a close relationship with the United States actively.

“Stay tuned to GeneOnline for more special articles on BioJapan 2018”

Author

GeneOnline

Related Post

go prime

German Startup BIOWEG Raises €16M to Tackle Plastic Waste with Biodegradables

2025-09-18

Trials & Approvals

GSK Scores FDA Approval for Nucala as Add-On Treatment to Reduce COPD Exacerbations

2025-05-23

go prime

Sumitomo Pharma’s Comeback Story: Reinventing a Century-Old Giant in a Post-Patent Era

2025-04-22